The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $204.65

Today's change+1.99 +0.98%
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $204.65

Today's change+1.99 +0.98%
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.

Allergan plc up (U.S.)$1.99

Allergan plc closed up Friday by (U.S.)$1.99 or 0.98% to (U.S.)$204.65. Shares have lost 7.10% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 30.86% during the last year.

Key company metrics

  • Open(U.S.) $202.50
  • Previous close(U.S.) $202.66
  • High(U.S.) $209.25
  • Low(U.S.) $201.42
  • Bid / Ask-- / --
  • YTD % change-2.55%
  • Volume3,903,828
  • Average volume (10-day)3,549,813
  • Average volume (1-month)2,475,568
  • Average volume (3-month)2,245,291
  • 52-week range(U.S.) $184.50 to (U.S.) $256.80
  • Beta1.17
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward12.62×
  • Forward PEG0.97×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.37%
  • Trailing EPS(U.S.) -$11.66
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue4,0073,5733,8643,622
Total other revenue--------
Total revenue4,0073,5733,8643,622
Gross profit3,4573,1233,3853,160
Total cost of revenue550450480462
Total operating expense5,0714,4794,7643,889
Selling / general / administrative1,3951,1851,2771,157
Research & development1,1931,1001,340665
Depreciation / amortization1,7581,7361,6391,609
Interest expense (income), net operating--------
Unusual expense (income)176729-5
Other operating expenses, total--------
Operating income-1,064-906-900-266
Interest income (expense), net non-operating-277-290-293-324
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,297-3,093-1,111-539
Income after tax-716-2,561-40-380
Income tax, total-581-532-1,071-159
Net income-726-2,565-115,220
Total adjustments to net income-70-70-70-70
Net income before extra. items-718-2,562-42-382
Minority interest-2-1-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-787-2,632-112-452
Inc. avail. to common incl. extra. items-796-2,635-7015,150
Diluted net income-796-2,635-7015,150
Dilution adjustment--------
Diluted weighted average shares335335356393
Diluted EPS excluding extraordinary itemsvalue per share-2.35-7.85-0.31-1.15
Dividends per sharevalue per share0.700.70--0.00
Diluted normalized EPSvalue per share-2.01-7.84-0.26-1.16